MIRATI THERAPEUTICS INC shareholders Q3 2023

MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 215 filers reported holding MIRATI THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.31 and the average weighting 0.7%.

MIRATI THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 92,887$4,046,1581.26%
TANG CAPITAL MANAGEMENT LLC 180,000$7,840,8001.11%
ARMISTICE CAPITAL, LLC 1,364,098$59,420,1090.91%
Ghost Tree Capital, LLC 60,000$2,613,6000.86%
Rhenman & Partners Asset Management AB 175,000$7,623,0000.82%
Affinity Asset Advisors, LLC 60,426$2,632,1570.74%
Vahanian & Associates Financial Planning Inc. 5,275$229,7790.74%
GREAT POINT PARTNERS LLC 86,302$3,759,3150.68%
Corton Capital Inc. 22,301$971,4320.49%
Neo Ivy Capital Management 24,720$1,0770.47%
Eventide Asset Management 600,000$26,136,0000.47%
Baker Brothers Advisors 1,409,784$61,410,1910.35%
Ghisallo Capital Management LLC 65,000$2,831,4000.29%
Candriam S.C.A. 893,763$38,932,3160.28%
Alpha DNA Investment Management LLC 14,423$628,2660.26%
Atom Investors LP 24,801$1,080,3320.25%
Assenagon Asset Management S.A. 1,825,678$79,526,5340.25%
Mach-1 Financial Group, LLC 12,737$554,8240.23%
Granahan Investment Management 145,175$6,323,8230.22%
FARALLON CAPITAL MANAGEMENT LLC 1,001,000$43,603,5600.22%
External links

This page lists MIRATI THERAPEUTICS INC's shareholders in Q3 2023. To view MIRATI THERAPEUTICS INC's shareholder history, click here.